# Ketamine for Pain in the Emergency Department

> **NCT03896230** · PHASE4 · TERMINATED · sponsor: **Hackensack Meridian Health** · enrollment: 11 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Ketamine Injectable Product

## Key facts

- **NCT ID:** NCT03896230
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-03
- **Primary completion:** 2019-12-20
- **Final completion:** 2019-12-20
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Due to resource limitations the study was on hold and was then terminated.
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03896230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03896230, "Ketamine for Pain in the Emergency Department". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03896230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*